175 related articles for article (PubMed ID: 35663355)
1. Preparation, characterization, and pharmacokinetics of rivaroxaban cocrystals with enhanced in vitro and in vivo properties in beagle dogs.
Meng Y; Tan F; Yao J; Cui Y; Feng Y; Li Z; Wang Y; Yang Y; Gong W; Yang M; Kong X; Gao C
Int J Pharm X; 2022 Dec; 4():100119. PubMed ID: 35663355
[TBL] [Abstract][Full Text] [Related]
2. Quabodepistat (OPC-167832), a Novel Antituberculosis Drug Candidate: Enhancing Oral Bioavailability via Cocrystallization and Mechanistic Analysis of Bioavailability in Two Cocrystals.
Sakamoto N; Miyata K; Fukami T
Mol Pharm; 2024 Jan; 21(1):358-369. PubMed ID: 38099729
[TBL] [Abstract][Full Text] [Related]
3. Preparation of quercetin-nicotinamide cocrystals and their evaluation under
Wu N; Zhang Y; Ren J; Zeng A; Liu J
RSC Adv; 2020 Jun; 10(37):21852-21859. PubMed ID: 35516602
[TBL] [Abstract][Full Text] [Related]
4. Improving the dissolution behaviors and bioavailability of abiraterone acetate via multicomponent crystal forms.
Yang Z; Yang Y; Xia M; Dai W; Zhu B; Mei X
Int J Pharm; 2022 Feb; 614():121460. PubMed ID: 35026315
[TBL] [Abstract][Full Text] [Related]
5. Piroxicam cocrystals with phenolic coformers: preparation, characterization, and dissolution properties.
Emami S; Adibkia K; Barzegar-Jalali M; Siahi-Shadbad M
Pharm Dev Technol; 2019 Feb; 24(2):199-210. PubMed ID: 29557714
[TBL] [Abstract][Full Text] [Related]
6. Explaining dissolution properties of rivaroxaban cocrystals.
Hriňová E; Skořepová E; Čerňa I; Královičová J; Kozlík P; Křížek T; Roušarová J; Ryšánek P; Šíma M; Slanař O; Šoóš M
Int J Pharm; 2022 Jun; 622():121854. PubMed ID: 35623488
[TBL] [Abstract][Full Text] [Related]
7. Two Novel Palbociclib-Resorcinol and Palbociclib-Orcinol Cocrystals with Enhanced Solubility and Dissolution Rate.
Duan C; Liu W; Tao Y; Liang F; Chen Y; Xiao X; Zhang G; Chen Y; Hao C
Pharmaceutics; 2021 Dec; 14(1):. PubMed ID: 35056919
[TBL] [Abstract][Full Text] [Related]
8. Formation of itraconazole-succinic acid cocrystals by gas antisolvent cocrystallization.
Ober CA; Gupta RB
AAPS PharmSciTech; 2012 Dec; 13(4):1396-406. PubMed ID: 23054991
[TBL] [Abstract][Full Text] [Related]
9. Fabrication of Carbamazepine Cocrystals: Characterization,
Wasim M; Mannan A; Asad MHHB; Amirzada MI; Shafique M; Hussain I
Biomed Res Int; 2021; 2021():6685806. PubMed ID: 33816628
[TBL] [Abstract][Full Text] [Related]
10. Isostructural cocrystals of metaxalone with improved dissolution characteristics.
Gohel SK; Palanisamy V; Sanphui P; Prakash M; Singh GP; Chernyshev V
RSC Adv; 2021 Sep; 11(49):30689-30700. PubMed ID: 35479860
[TBL] [Abstract][Full Text] [Related]
11. Effect of Surfactants and Polymers on the Dissolution Behavior of Supersaturable Tecovirimat-4-Hydroxybenzoic Acid Cocrystals.
Feng Y; Meng Y; Tan F; Lv L; Li Z; Wang Y; Yang Y; Gong W; Yang M
Pharmaceutics; 2021 Oct; 13(11):. PubMed ID: 34834187
[TBL] [Abstract][Full Text] [Related]
12. Novel Aceclofenac-l-Cystine and Aceclofenac-Urea Cocrystals with Enhanced Oral Bioavailability.
Kumar S; Gupta A; Mishra CK; Singh S
Curr Drug Deliv; 2021; 18(8):1174-1181. PubMed ID: 33602085
[TBL] [Abstract][Full Text] [Related]
13. Design and Optimization of Rivaroxaban-Cyclodextrin-Polymer Triple Complex Formulation with Improved Solubility.
Kang JH; Lee JE; Jeong SJ; Park CW; Kim DW; Weon KY
Drug Des Devel Ther; 2022; 16():4279-4289. PubMed ID: 36561308
[TBL] [Abstract][Full Text] [Related]
14. Interrelation of the dissolution behavior and solid-state features of acetazolamide cocrystals.
Arenas-García JI; Herrera-Ruiz D; Morales-Rojas H; Höpfl H
Eur J Pharm Sci; 2017 Jan; 96():299-308. PubMed ID: 27650458
[TBL] [Abstract][Full Text] [Related]
15. Crystal structures, dissolution and pharmacokinetic study on a novel phosphodiesterase-4 inhibitor chlorbipram cocrystals.
Zhou J; Li L; Zhang H; Xu J; Huang D; Gong N; Han W; Yang X; Zhou Z
Int J Pharm; 2020 Feb; 576():118984. PubMed ID: 31870960
[TBL] [Abstract][Full Text] [Related]
16. A nano-cocrystal strategy to improve the dissolution rate and oral bioavailability of baicalein.
Pi J; Wang S; Li W; Kebebe D; Zhang Y; Zhang B; Qi D; Guo P; Li N; Liu Z
Asian J Pharm Sci; 2019 Mar; 14(2):154-164. PubMed ID: 32104447
[TBL] [Abstract][Full Text] [Related]
17. Solid State Characterization and Dissolution Enhancement of Nevirapine Cocrystals.
Panzade P; Shendarkar G; Kulkarni D; Shelke S
Adv Pharm Bull; 2021 Sep; 11(4):772-776. PubMed ID: 34888225
[No Abstract] [Full Text] [Related]
18. Dehydroepiandrosterone Cocrystals with Improved Solubility and Bioavailability.
Jiang Y; Cheng Y; Xia M; Zhang B; Ding Q; Lu L; Wang JR; Mei X
Pharmaceutics; 2022 Nov; 14(11):. PubMed ID: 36432669
[TBL] [Abstract][Full Text] [Related]
19. Cocrystals of diacerein: Towards the development of improved biopharmaceutical parameters.
Tomar S; Chakraborti S; Jindal A; Grewal MK; Chadha R
Int J Pharm; 2020 Jan; 574():118942. PubMed ID: 31830577
[TBL] [Abstract][Full Text] [Related]
20. Chitosan-telmisartan polymeric cocrystals for improving oral absorption: In vitro and in vivo evaluation.
Ganesh M; Ubaidulla U; Rathnam G; Jang HT
Int J Biol Macromol; 2019 Jun; 131():879-885. PubMed ID: 30905757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
